Lower open as jobless claims rise

An increase in first time applications for unemployment benefits weighed the markets down to a lower open with the Dow falling 55 points to 16,229. Nasdaq dropped 23 points to 4,596.

On the upside

Sarepta Therapeutics (Nasdaq: SRPT) reported additional positive data from a Phase IIb study of its Duchenne muscular dystrophy drug eteplirsen.

Pacific Biosciences of California (Nasdaq: PACB) launched a new nucleic acid sequencing platform.

PBF Energy (NYSE: PBF) will acquire Exxon Mobil's (NYSE: XOM) in Torrance for approximately $537.5 million.

On the downside

Dunkin' Brands Group (Nasdaq: DNKN) forecast third revenue below analyst expectations and announced plans to close 100 stores.

Crocs (Nasdaq: CROX) cut its third quarter sales guidance.

Illumina (Nasdaq: ILMN) launched the BaseSpace Professional and Enterprise Editions of its Laboratory Information Management Systems solutions but the stock price fell.

In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 3 on the NYSE while decliners edged out advancers by nearly 10 to 9 on Nasdaq. The broader S&P 500 slipped 3 points to 1,916. Bitcoin held steady at $235.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.